Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Elevance Health Inc Formerly (ELV)

2K + Investors. Track Smart Money conviction in ELV. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +150
Streak
1Q ▲
Buyers last Q
56%

Smart Money Signals — ELV

Based on 1615 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added ELV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (98% of max)

98% of all-time peak
1,615 hedge funds hold ELV right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding ELV is almost the same as a year ago (+47 funds, +3% change). No significant rush to buy or sell — institutional backing is holding steady.
🟡

Slight buying edge — 56% buying

881 buying683 selling
Last quarter: 881 funds bought or added vs 683 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+128 vs last Q)

new funds entering per quarter
Funds opening a new ELV position: 172 → 222 → 153 → 281. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

67% of holders stayed for 2+ years

■ 67% conviction (2yr+) ■ 17% medium ■ 15% new
1,084 out of 1,615 hedge funds have held ELV for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +63%, value +32%

Value
+31%
Shares
+62%
Last quarter: funds added +63% more shares while total portfolio value only changed +32%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

155 → 172 → 222 → 153 → 281 new funds/Q
New funds entering each quarter: 172 → 222 → 153 → 281. A growing number of institutions are discovering ELV each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 72% veterans vs 17% newcomers

■ 72% veterans ■ 10% 1-2yr ■ 17% new
Entry-cohort mix of 1,668 holders: 1,204 (72%) are 2+ year veterans, 174 entered 1–2 years ago, and 290 (17%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 54% AUM from top-100 funds

54% from top-100 AUM funds
70 of 1603 holders are among the 100 largest funds by AUM, controlling 54% of total institutional value in ELV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.3
out of 10
Low Exit Risk
Exit risk score 3.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ELV

In 2026 Q2, 881 hedge funds were net buyers of ELV (281 opened a new position, 600 added to an existing one), while 683 reduced or exited (552 trimmed, 131 sold completely) — a 56% buyer ratio, indicating a slight buying edge. 54% of total institutional value in ELV is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +150 funds (more new holders than closures). Total institutional holders: 1615.

Hedge Fund Ownership: ELV

How many hedge funds hold ELV — quarterly history vs. share price
Quarterly hedge fund ownership of ELV vs. share price

Market Analysis: ELV

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ELV

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Elevance Health Inc Formerly (ELV) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ELV has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 89d ago
ELV
+2.4%
XLV
-8.3%

ELV outperformed XLV by +10.7% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 44d ago
ELV
-0.6%
XLV
-11.6%

Since the filing became public, ELV outperformed XLV by +11.0% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

46 top-rated funds 20 high-conviction
Consensus
7.3
/ 10
breadth
×
Elite
5.0
/ 10
conviction
Hedge Fund Positioning: ELV
2K + Investors

Track Smart Money conviction in ELV. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 1587 1465 8.33%
13F Shares 200M 199M 0.51%
Total Value $72.82B $55.52B 31.16%
New Positions 277 153 +124
Increased Positions 583 478 +105
Closed Positions 143 232 -89
Reduced Positions 531 637 -106
Total Calls 32 25 28.0%
Total Puts 30 24 25.0%
PUT/CALL Ratio 0.94 0.96 Neutral

Statistics: ELV

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

2K + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ELV. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ELV holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 High Ground Investment Management LLP 23.09% 679,904 $262.9M
2 Grafton Street Partners Management Company, LLC 8.90% 41,691 $16.1M
3 Brave Warrior Advisors, LLC 8.23% 976,885 $377.8M
4 Hyperion Capital Advisors LP 7.49% 42,924 $16.6M
5 Brooklands Fund Management Ltd 6.91% 21,102 $8.8M
6 Focused Investors LLC 6.03% 461,600 $178.5M
7 Ruane, Cunniff & Goldfarb L.P. 5.89% 979,598 $378.8M
8 Unison Asset Management LLC 4.58% 29,175 $11.3M
9 Cobalt Capital Management, INC. 4.13% 15,000 $5.8M
10 ACR Alpine Capital Research, LLC 4.05% 737,922 $285.4M
11 Summit Street Capital Management, LLC 3.91% 72,040 $27.9M
12 Stanley Capital Management, LLC 3.73% 72,819 $28.2M
13 Sector Gamma As 3.73% 44,499 $17.2M
14 Redwood Capital Management, LLC 3.54% 84,800 $32.8M
15 Marathon Asset Management Ltd 3.45% 219,490 $84.9M
16 Firetrail Investments Pty Ltd 3.42% 31,530 $12.1M
17 Palmer Knight Co 3.30% 22,163 $8.6M
18 Evergreen Wealth Management, LLC 3.17% 17,473 $6.8M
19 Veritas Asset Management LLP 2.98% 428,672 $165.8M
20 Sound Shore Management Inc /Ct/ 2.90% 243,452 $94.2M
21 Artisan Partners Limited Partnership 2.81% 4,581,222 $1.77B
22 English Capital Management LLC 2.79% 22,018 $6.1M
23 Allen Mooney & Barnes Investment Advisors LLC 2.73% 46,398 $17.9M
24 First Eagle Investment Management, LLC 2.70% 4,188,196 $1.62B
25 Caden Capital Partners, LP 2.63% 564 $218K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Elevance Health Inc Formerly (ELV)

What does the Smart Money Trend signal show for ELV?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ELV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ELV?

Slight buying edge — 56% buying: Last quarter: 881 funds bought or added vs 683 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ELV holders?

Elite ownership — 54% AUM from top-100 funds: 70 of 1603 holders are among the 100 largest funds by AUM, controlling 54% of total institutional value in ELV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ELV?

67% of holders stayed for 2+ years: 1,084 out of 1,615 hedge funds have held ELV for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Elevance Health Inc Formerly (ELV) following the 2026 Q2 hedge fund 13F filings?

As of today, ELV has moved -0.6% since the 2026 Q2 13F filing date (August 14, 2026), compared to -11.6% for the XLV sector ETF — an outperformance of +11.0%. Since the quarter end (June 30, 2026), ELV has gained +2.4% vs -8.3% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →